LA JOLLA, Calif., Sept. 11 /PRNewswire/ -- TorreyPines Therapeutics, Inc. today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at ThinkEquity’s G5 Conference in San Francisco on Tuesday, September 18th at 2:30 p.m., local time (5:30 p.m., Eastern).
A webcast of Dr. Kurtz’s presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.
About TorreyPines Therapeutics
TorreyPines Therapeutics, Inc. is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel small molecules to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, including cognitive impairment associated with schizophrenia and Alzheimer’s disease. Further information is available at http://www.torreypinestherapeutics.com.
TorreyPines Therapeutics, Inc.
CONTACT: company, Craig Johnson of TorreyPines Therapeutics, Inc.,+1-858-623-5665, ext. 158, cjohnson@torreypinestherapeutics.com; or media,Patricia Garrison, +1-917-322-2567, pgarrison@RxIR.com, or investors,Rhonda Chiger, +1-917-322-2569, rchiger@RxIR.com, both of RxCommunications, for TorreyPines Therapeutics, Inc.
Web site: http://www.torreypinestherapeutics.com/
